{"id":441,"date":"2014-10-03T13:53:00","date_gmt":"2014-10-03T09:53:00","guid":{"rendered":"http:\/\/uig-ae.com\/?guid=ea91ac7063d03a3bc0a489bb2523c278"},"modified":"2014-10-03T13:53:00","modified_gmt":"2014-10-03T09:53:00","slug":"tax-inversion-deal-collapses-will-others-follow-suit","status":"publish","type":"post","link":"http:\/\/uig-ae.com\/?p=441","title":{"rendered":"Tax inversion deal collapses: Will others follow suit?"},"content":{"rendered":"A planned $2.7 billion deal between pharma companies Salix and Cosmo, motivated in part by the opportunity to do a tax inversion, has fallen through.","protected":false},"excerpt":{"rendered":"<p>A planned $2.7 billion deal between pharma companies Salix and Cosmo, motivated in part by the opportunity to do a tax inversion, has fallen through.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[],"_links":{"self":[{"href":"http:\/\/uig-ae.com\/index.php?rest_route=\/wp\/v2\/posts\/441"}],"collection":[{"href":"http:\/\/uig-ae.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/uig-ae.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/uig-ae.com\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"http:\/\/uig-ae.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=441"}],"version-history":[{"count":0,"href":"http:\/\/uig-ae.com\/index.php?rest_route=\/wp\/v2\/posts\/441\/revisions"}],"wp:attachment":[{"href":"http:\/\/uig-ae.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/uig-ae.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=441"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/uig-ae.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}